ri305b2.htm
                                                                                                 Registration No. 333-158169
 
 
FORM T-1
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
 
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)           | x |
___________________________
 
THE BANK OF NEW YORK MELLON
TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
 
 
(State of incorporation
if not a U.S. national bank)
95-3571558
(I.R.S. employer
identification no.)
 
700 South Flower Street
Suite 500
Los Angeles, California
(Address of principal executive offices)
 
 
 
90017
(Zip code)

 
___________________________
 
REALTY INCOME CORPORATION
(Exact name of obligor as specified in its charter)
 
Maryland
(State or other jurisdiction of
incorporation or organization)
33-0580106
(I.R.S. employer
identification no.)
 
600 La Terraza Boulevard
Escondido, California
(Address of principal executive offices)
 
 
92025-3873
(Zip code)
___________________________
 

 
Debt Securities
(Title of the indenture securities)
 
 
 
 
 
 
1.           General information.  Furnish the following information as to the trustee:
 
 
(a)
Name and address of each examining or supervising authority to which it is subject.
 
Name
Address
Comptroller of the Currency
United States Department of the Treasury
 
 
Washington, D.C. 20219
Federal Reserve Bank
San Francisco, California 94105
 
Federal Deposit Insurance Corporation
 
Washington, D.C. 20429
 
 (b)
Whether it is authorized to exercise corporate trust powers.
 
Yes.
 
2.
Affiliations with Obligor.
 
If the obligor is an affiliate of the trustee, describe each such affiliation.
 
None.
 
16.
List of Exhibits.
 
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the "Act") and 17 C.F.R. 229.10(d).
 
 
1.
A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875).
 
 
2.
A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948).
 
 
3.
A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875).
 
 
- 2 -
 
 
4.
A copy of the existing by-laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-162713).
 
 
6.
The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875).
 
 
7.
A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
 
 
- 3 -
 
SIGNATURE
 
Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Los Angeles, and State of California, on the 17th day of June, 2010.
 
  THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.  
       
 
By:
/S/ RAYMOND TORRES  
    Name: RAYMOND TORRES  
    Title:    SENIOR ASSOCIATE  
       
                                          

 
 
- 4 -
 

 
EXHIBIT 7

Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 700 South Flower Street, Suite 200, Los Angeles, CA 90017

At the close of business March 31, 2010, published in accordance with Federal regulatory authority instructions.


                                                                                                                                   Dollar Amounts
                 in Thousands
ASSETS

Cash and balances due from
depository institutions:
Noninterest-bearing balances
  and currency and coin…………………………………………………………….. ………1,504
Interest-bearing balances…………………………………………………………….. ………288
Securities:
Held-to-maturity securities…………………………………………………………….. ………12
Available-for-sale securities……………………………………………………………..  581,259
Federal funds sold and securities
purchased under agreements to resell:
Federal funds sold…………………………………………………………….. …………113,000
Securities purchased under agreements to resell………………………………………………   0
Loans and lease financing receivables:
Loans and leases held for sale…………………………………………………………….. ……0
Loans and leases,
  net of unearned income………………………………….0
LESS: Allowance for loan and
  lease losses………………………………………………0
Loans and leases, net of unearned
  income and allowance…………………………………………………………….. …………  0
Trading assets…………………………………………………………….. …………… ………………0
Premises and fixed assets (including
capitalized leases)…………………………………………………………….. …………  10,486
Other real estate owned…………………………………………………………….. …………… ……0
Investments in unconsolidated
subsidiaries and associated
companies…………………………………………………………….. …………… …………2
Direct and indirect investments in real estate ventures …………………………………………………0
Intangible assets:
      Goodwill…………………………………………………………….. …………… …………856,313
      Other intangible assets…………………………………………………………….. ………   237,642
Other assets…………………………………………………………….. …………… …………166,465
Total assets…………………………………………………………….. …………… ……… $1,966,971

 
 
1
 
 
LIABILITIES

Deposits:
       In domestic offices  …………………………………………………………….. …………… 533
Noninterest-bearing……………………………………………………………..  533
Interest-bearing…………………………………………………………….……  0
       Not applicable
Federal funds purchased and securities
sold under agreements to repurchase:
Federal funds purchased …………………………………………………………….. ……  0
Securities sold under agreements to repurchase……………………………………………   0
Trading liabilities…………………………………………………………….. …………… ………   0
Other borrowed money:
(includes mortgage indebtedness
and obligations under capitalized
leases)…………………………………………………………….. …………… ……268,691
Not applicable
Not applicable
Subordinated notes and debentures…………………………………………………………….. ……0
Other liabilities…………………………………………………………….. …………… ……210,010
Total liabilities…………………………………………………………….. …………… …… 479,234
Not applicable

EQUITY CAPITAL

Perpetual preferred stock and related surplus…………………………………………………………0
Common stock…………………………………………………………….. …………… ………1,000
Surplus (exclude all surplus related to preferred stock)……………………………………… 1,121,520
Not applicable
   Retained earnings…………………………………………………………….. ……………  364,077
   Accumulated other comprehensive income …………………………………………………… 1,140
Other equity capital components                                                                                                     0  
Not available
    Total bank equity capital …………………………………………………………………  1,487,737
    Noncontrolling (minority) interests in consolidated subsidiaries……………………………………  0
Total equity capital…………………………………………………………….. …………… 1,487,737
Total liabilities and equity capital…………………………………………………………….. 1,966,971


I, Karen Bayz, Managing Director of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

Karen Bayz     )           Managing Director


We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.


Troy Kilpatrick, President       )
Frank P. Sulzberger, MD        )           Directors (Trustees)
William D. Lindelof, MD        )

 
 2